Australasian Science: Australia's authority on science since 1938

Stem Cell Industry Must Tread a Fine Line

By Richard Harvey, Martin Pera and Megan Munsie

The emerging stem cell industry needs to be able to fast-track therapies into clinical trials without clearing the way for clinics to offer unproven therapies to vulnerable patients.

To view this article subscribe or purchase a yearly pass here.